8/6/2019 Congenital Rubella Kbk
http://slidepdf.com/reader/full/congenital-rubella-kbk 1/15
CONGENITAL RUBELLA CONGENITAL RUBELLA
SYNDROMESYNDROMEInfectious and TropicalInfectious and Tropical PediatricPediatric DivisionDivision
Department of Child HealthDepartment of Child Health
Medical Faculty, University of Sumatera UtaraMedical Faculty, University of Sumatera Utara
8/6/2019 Congenital Rubella Kbk
http://slidepdf.com/reader/full/congenital-rubella-kbk 2/15
What is RubellaWhat is Rubella
R ubella (German measles) is a diseaseR ubella (German measles) is a diseasecaused by the rubella virus. R ubella iscaused by the rubella virus. R ubella isusually a mild illness. Most people whousually a mild illness. Most people whohave had rubella or the vaccine arehave had rubella or the vaccine areprotected against the virus for the rest of protected against the virus for the rest of their lives. Because of routine vaccinationtheir lives. Because of routine vaccinationagainst rubella since 1970 , rubella is nowagainst rubella since 1970 , rubella is nowrarely reported.rarely reported.
8/6/2019 Congenital Rubella Kbk
http://slidepdf.com/reader/full/congenital-rubella-kbk 3/15
HistoryHistory -- RubellaRubella
The Teratogenic property of theThe Teratogenic property of the
infection was documented by aninfection was documented by anAustralian opthalmologist Greeg inAustralian opthalmologist Greeg in
19411941
8/6/2019 Congenital Rubella Kbk
http://slidepdf.com/reader/full/congenital-rubella-kbk 4/15
RubellaRubella
( German Measles )( German Measles ) R ubella is alsoR ubella is also
called as 3 daycalled as 3 dayMeasles or GermanMeasles or German
Measles.Measles. FamilyFamily ±± TogaviridaeTogaviridae
GenusGenus -- RubivirusRubivirus
In general belongIn general belongto Togavirus groupto Togavirus group
8/6/2019 Congenital Rubella Kbk
http://slidepdf.com/reader/full/congenital-rubella-kbk 5/15
Rubella VirusRubella Virus
R ubella virus areR ubella virus are
ssss ±± RNA virusRNA virus
Diameter 50Diameter 50 ±± 70 nm70 nm
Enveloped SphericalEnveloped Spherical
Virus carryVirus carryhemagglutininhemagglutinin
Virus multiply in theVirus multiply in thecytoplasam of infectedcytoplasam of infectedcell.cell.
8/6/2019 Congenital Rubella Kbk
http://slidepdf.com/reader/full/congenital-rubella-kbk 6/15
EpidemiologyEpidemiology
R ubella is world wide in distributionR ubella is world wide in distribution
Occurs round the year,Occurs round the year,
Epidemics occur every 20Epidemics occur every 20 ±± 25 years25 years
Infection is transmitted by respiratoryInfection is transmitted by respiratoryrouteroute
The use of R ubella vaccine has nowThe use of R ubella vaccine has noweliminated both epidemic and endemiceliminated both epidemic and endemicR ubella in USA and several developedR ubella in USA and several developedcountriescountries
8/6/2019 Congenital Rubella Kbk
http://slidepdf.com/reader/full/congenital-rubella-kbk 7/15
Tr eatment and Pr eventionTr eatment and Pr evention
R ubella is a mild self limited illness.R ubella is a mild self limited illness.
No specific treatment or AntiviralNo specific treatment or Antiviral
treatment is indicated.treatment is indicated.However Laboratory proved andHowever Laboratory proved and
clinically missed R ubella in the Ist 3clinically missed R ubella in the Ist 3--4 months of pregnancy is associated4 months of pregnancy is associatedwith fetal infections.with fetal infections.
8/6/2019 Congenital Rubella Kbk
http://slidepdf.com/reader/full/congenital-rubella-kbk 8/15
Congenital Rubella SyndromeCongenital Rubella Syndrome
Maternal viremia with R ubella infectionMaternal viremia with R ubella infectionduring pregnancy may result in infectionduring pregnancy may result in infectionof placenta and fetus.of placenta and fetus.
The growth rate of fetal cells are reduced.The growth rate of fetal cells are reduced. R esults in fewer number of cells after theR esults in fewer number of cells after the
birth.birth.
Lead to deranged and hypo plastic organLead to deranged and hypo plastic organ
development.development. R esults in structural damage andR esults in structural damage and
abnormalitiesabnormalities
8/6/2019 Congenital Rubella Kbk
http://slidepdf.com/reader/full/congenital-rubella-kbk 9/15
Rubella infectionRubella infection ² ² At various At various
trimesterstrimesters
IIstst trimester infections lead to abnormalities intrimester infections lead to abnormalities in85 % of cases. and greater damage to organs85 % of cases. and greater damage to organs
22
ndnd
trimester infections lead to defects in 16 %trimester infections lead to defects in 16 % > 20 weeks of pregnancy fetal defects are> 20 weeks of pregnancy fetal defects are
uncommonuncommon
However R ubella infection can also lead to fetalHowever R ubella infection can also lead to fetaldeaths, and spontaneous abortion.deaths, and spontaneous abortion.
The intrauterine infections lead to viral excretionThe intrauterine infections lead to viral excretionin various secretion in newborn upto 12in various secretion in newborn upto 12--1818months.months.
8/6/2019 Congenital Rubella Kbk
http://slidepdf.com/reader/full/congenital-rubella-kbk 10/15
Clinical FindingsClinical Findings
(C
ongenital Rubella Syndr ome )(
Congenital Rubella Synd
r ome )
May be transient effects in infants.May be transient effects in infants.
Permanent manifestations may bePermanent manifestations may be
apparent at birth, becomeapparent at birth, becomerecognized during the first year.recognized during the first year.
Developmental abnormalities appearDevelopmental abnormalities appearduring childhood and adolescents.during childhood and adolescents.
8/6/2019 Congenital Rubella Kbk
http://slidepdf.com/reader/full/congenital-rubella-kbk 11/15
Classical Tr iad of RubellaClassical Tr iad of Rubella
Classical TriadClassical Triad CataractCataract
Cardiac abnormalitiesCardiac abnormalities
DeafnessDeafness
Other manifestationsOther manifestationsGrowth retardationGrowth retardation
RashRashHepatosplenomegalyHepatosplenomegaly
JaundiceJaundiceMeingoencephalitisMeingoencephalitisCNS defects lead toCNS defects lead tomoderate to profoundmoderate to profound
mental retardationmental retardation
8/6/2019 Congenital Rubella Kbk
http://slidepdf.com/reader/full/congenital-rubella-kbk 12/15
Other Neur ological manifestionsOther Neur ological manifestions
Problems in balanceProblems in balance
Motor skills inMotor skills inpreschool childrenpreschool children
altered.altered. A rare complication of A rare complication of
Pan encephalitis canPan encephalitis canoccur in secondoccur in seconddecade withdecade with
Congenital rubellaCongenital rubellasyndrome maysyndrome mayprogress to death.progress to death.
8/6/2019 Congenital Rubella Kbk
http://slidepdf.com/reader/full/congenital-rubella-kbk 13/15
Diagnosis of Diagnosis of
Congenital Rubella Synd
r
omeC
ongenital Rubella Syndr
ome
Demonstration of Demonstration of R ubella antibodiesR ubella antibodies
of IgM in a newof IgM in a newborn is diagnosticborn is diagnosticvalue. As IgMvalue. As IgMgroup donot crossgroup donot crossthe placenta andthe placenta andthey are produce inthey are produce inthe infected fetus,the infected fetus,
8/6/2019 Congenital Rubella Kbk
http://slidepdf.com/reader/full/congenital-rubella-kbk 14/15
Treatment, Prevention, ControlTreatment, Prevention, Control
No specific treatmentNo specific treatmentis availableis available
CRS can be prevented by CRS can be prevented by
effective immunization of effective immunization of the young children and the young children and
teenage girls, remain theteenage girls, remain the
best option to prevent best option to prevent
Congenital RubellaCongenital Rubella
Syndrome.Syndrome.
The component of The component of
Rubella in MMR vaccineRubella in MMR vaccine
protects the vaccinated protects the vaccinated
8/6/2019 Congenital Rubella Kbk
http://slidepdf.com/reader/full/congenital-rubella-kbk 15/15
MMR VaccineMMR Vaccine
TheThe MMR vaccineMMR vaccine is a mixture of three liveis a mixture of three liveattenuated virusesattenuated viruses, administered via injection for, administered via injection forimmunizationimmunization againstagainst measlesmeasles,, mumpsmumps andandrubellarubella. It is generally administered to children. It is generally administered to children
around the age of one year, with a second dosearound the age of one year, with a second dosebefore starting school (i.e. age 4/5). The secondbefore starting school (i.e. age 4/5). The seconddose is not adose is not a boosterbooster; it is a dose to produce; it is a dose to produceimmunity in the small number of persons (2immunity in the small number of persons (2--5%)5%)who fail to develop measles immunity after thewho fail to develop measles immunity after the
first dose In the United States, the vaccine wasfirst dose In the United States, the vaccine waslicensed in 1963 and the second dose waslicensed in 1963 and the second dose wasintroduced in the mid 1990s. It is widely used inintroduced in the mid 1990s. It is widely used inall National, Universal Immunization programmesall National, Universal Immunization programmes
Top Related